Compile Data Set for Download or QSAR
Report error Found 1774 of affinity data for UniProtKB/TrEMBL: P21730
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134531BDBM134531(US8846656, 23-I)
Affinity DataIC50: 0.5nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134505BDBM134505(US8846656, 21-D)
Affinity DataIC50: 0.5nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134518BDBM134518(US8846656, 21-AG)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at C5aR1 in human neutrophils assessed as inhibition of recombinant human C5a-induced chemotaxis preincubated for 30 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134520BDBM134520(US8846656, 21-AI)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134523BDBM134523(US8846656, 21-AL)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134596BDBM134596(US8846656, 69-L)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134589BDBM134589(US8846656, 65-I)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at C5aR1 in human U937 cells assessed as inhibition of recombinant human C5a-induced chemotaxis preincubated for 30 mins followed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at C5aR1 in human U937 cells assessed as inhibition of recombinant human C5a-induced intracellular calcium mobilization preincuba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134569BDBM134569(US8846656, 52-C)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at recombinant human C5aR1 expressed in Sf9 insect cell membranes co-expressing G-alphai2,G-beta1 and G-gamma2 assessed as inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134586BDBM134586(US8846656, 65-A)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134574BDBM134574(US8846656, 55-I)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134530BDBM134530(US8846656, 23-H)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134580BDBM134580(US8846656, 56-C)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at C5aR1 in human blood granulocytes assessed as inhibition of recombinant human C5a-induced CD11b expression on granulocytes pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134500BDBM134500(US8846656, 19-AF)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at C5aR1 in human HL60 cells assessed as inhibition of recombinant human C5a-induced oxidative burst after 30 mins by fluorescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462093BDBM50462093(CHEMBL4245250)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at C5aR1 in human U937 cells assessed as inhibition of recombinant human C5a-induced cell degranulation preincubated for 30 mins ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134512BDBM134512(US8846656, 21-R)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134577BDBM134577(US8846656, 55-M)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134519BDBM134519(US8846656, 21-AH)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134511BDBM134511(US8846656, 21-Q)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134582BDBM134582(US8846656, 56-F)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134524BDBM134524(US8846656, 21-AM)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50012295BDBM50012295(Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg | CHEMBL21...)
Affinity DataEC50:  1.30nMAssay Description:Ability to induce shape change (polarization) in human polymorphonuclear leukocytes (PMN)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50587360BDBM50587360(CHEMBL5082686)
Affinity DataEC50:  1.5nMAssay Description:Agonist activity at human C5aR1 expressed in CHO cells assessed as induction of ERK1/2 phosphorylation at Thr202/Tyr204 residues incubated for 10 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50275728BDBM50275728(N-(4-chlorophenethyl)-2-isobutyl-N-(1,4-dioxaspiro...)
Affinity DataIC50: 1.5nMAssay Description:Displacement of [125I]r-hC5a from C5a receptor in cAMP differentiated human U937 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134581BDBM134581(US8846656, 56-E)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134591BDBM134591(US8846656, 68-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134587BDBM134587(US8846656, 65-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134590BDBM134590(US8846656, 65-K)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134571BDBM134571(US8846656, 54-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134479BDBM134479(US8846656, 17-AM)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134529BDBM134529(US8846656, 23-G)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134546BDBM134546(US8846656, 29)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134498BDBM134498(US8846656, 19-AD)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462086BDBM50462086(CHEMBL1628668)
Affinity DataIC50: 2nMAssay Description:Antagonist activity at C5aR1 in human neutrophils assessed as inhibition of 0.1 nM recombinant human C5a-induced intracellular calcium releaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134572BDBM134572(US8846656, 55-G)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134579BDBM134579(US8846656, 56-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134509BDBM134509(US8846656, 21-N)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134551BDBM134551(US8846656, 32-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134601BDBM134601(US8846656, 71-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134507BDBM134507(US8846656, 21-K)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134525BDBM134525(US8846656, 22-C)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134502BDBM134502(US8846656, 19-AI)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50587361BDBM50587361(CHEMBL5092578)
Affinity DataEC50:  2.60nMAssay Description:Agonist activity at human C5aR1 expressed in CHO cells assessed as induction of ERK1/2 phosphorylation at Thr202/Tyr204 residues incubated for 10 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2023
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50266072BDBM50266072((+/-)-ethyl 2-(N-(1,4-dioxaspiro[4.5]decan-8-yl)-1...)
Affinity DataIC50: 3nMAssay Description:Displacement of [125I]C5a from C5a receptor in cAMP differentiated human U937 cells by filtration assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50462086BDBM50462086(CHEMBL1628668)
Affinity DataIC50: 3nMAssay Description:Antagonist activity at C5aR1 in HMDM assessed as inhibition of 1 nM recombinant human C5a-induced intracellular calcium release preincubated for 1 hr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 1774 total ) | Next | Last >>
Jump to: